Renner AC
North Dakota State University, Fargo, North Dakota 58108-6050, United States.
ArticleDMT
Advancing Next-Generation Psychedelic Therapeutics through Selective 5‑HT2A Activation, Precision Aerosol Delivery, and Optimized 5‑MeO-DMT Treatment Paradigms.
ArticlePsilocybin
Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics.
ArticlePsychedelics
From Solid-State Control to Predictive Precision: Building a Deployable Ecosystem for Psychedelic Therapeutics.
ArticlePsilocybin
Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT Formulations.
ArticleDMT
Molecular Diagnostics, Circuit-Calming Modulators, and Controlled Neuroplastogens: Emerging Strategies in Precision Neuropsychiatric Therapeutics.
ArticlePsilocybin
Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control.
ArticlePsilocybin
Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.
ArticlePsilocybin